Champignon Brands (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496), a
human optimization sciences company with an emphasis on ketamine and
psychedelic medicine, on Tuesday announced the execution of a term sheet with
California-based Wellness Clinic of Orange County Inc., further advancing the
company’s North American clinical expansion. Per the term sheet, SHRMF is to
acquire 100% of the Wellness Clinic and all of its subsidiaries in exchange for
payments over an 18-month period totaling: (a) USD $600,000; (b) 1 million
common shares of Champignon (the “Initial Share Issuance”); and, (C) 500,000
common shares of Champignon payable only if the Wellness Clinic collects
top-line revenue of at least USD $1,500,000, over the 18-month period, post
closing (the “Second Share Issuance”). The Initial Share Issuance will be paid
upon closing of the acquisition, subject to a 12-month escrow, with 500,000
common shares released 6 months after closing and the remaining 500,000 shares
released 12-months after closing. Both share issuances are to be issued at a
price per share determined using the average trading price of the common shares
in accordance with the Canadian Securities Exchange policies and applicable
securities law. “We are thrilled to begin executing on our North American
expansion strategy by acquiring our first U.S. based, revenue generating
ketamine centre- Wellness Clinic of Orange County,” Champignon CEO Dr. Roger
McIntyre stated in the news release. “This acquisition represents a major
milestone as we begin to accelerate our vision of establishing significant
scale and a sizable footprint of integrated ketamine centric clinics committed
to providing innovative care and therapeutic options to improve the quality of
life of patients suffering from chronic disease states that have failed
conventional treatments.”
To view the full press release, visit http://ibn.fm/RQAhd
About Champignon Brands Inc.
Champignon Brands (CSE: SHRM) is focused on the formulation
and manufacturing of novel ketamine, anaesthetics and adaptogenic delivery
platforms for the nutraceutical and psychedelic medicine while being supported
by a leading psychedelics medicines clinic platform. The Company is pursuing
the development and commercialization of rapid onset treatments capable of
improving health outcomes, such as depression and post-traumatic stress
disorder (“PTSD”), as well as substance and alcohol use disorders. Under a
collaborative research agreement with the University of Miami’s Miller School
of Medicine, the Company is conducting preclinical studies and eventual human
clinical trials, with the objective of demonstrating safety and efficacy of the
combination of psilocybin and cannabidiol in treating mTBI with PTSD or
stand-alone PTSD. Champignon continues to be inspired by sustainability, as its
medicinal mushroom-infused SKUs are organic, non-GMO and vegan certified. For
more information, visit the Company’s website at www.ChampignonBrands.com.
NOTE TO INVESTORS: The latest news and updates
relating to SHRM are available in the company’s newsroom at http://ibn.fm/SHRM
About QualityStocksNewsBreaks
QualityStocksNewsBreaks provide
a rapid summary of corporate news that catch the attention of QualityStocks.
QualityStocksBreaks are designed to keep investors up to date on important and
breaking news in the small-cap and micro-cap markets. Spanning all industries,
including energy, entertainment, telecommunications, healthcare, retail and
more, these news breaks deliver opportunities the investment community may have
missed. Whether it is earnings results, mergers and acquisitions, or any other
market-moving news, our news breaks keep you in the know. QualityStocks is
committed to connecting subscribers with companies that have huge potential to
succeed in the short and long-term future. It is part of our mission statement
to help the investment community discover emerging companies that offer
excellent growth potential.
QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Please see full terms of use and disclaimers on the
QualityStocks website applicable to all content provided by QS, wherever
published or re-republished: http://www.qualitystocks.net/disclaimer.php

No comments:
Post a Comment